Substantial weight loss achieved through GLP-1 therapy might therefore improve RA symptoms by reducing this inflammatory burden
doi: 10.1080/25785826.2024.2360664 188 DacekMMKurtzKGWallischPPierreSAKhayatSBourneCMet al
If a person has too little GLP-1, this may lead to a person eating more during meals or snacking between meals
Older GLP-1 medications such as exenatide may be less expensive than newer agents like semaglutide, though they may require more frequent dosing and have different efficacy profiles
Yang Y, Cui X, Chen Y, Wang Y, Li X, Lin L, Zhang H (2014) Exendin-4, an analogue of glucagon-like peptide-1, attenuates hyperalgesia through serotonergic pathways in rats with neonatal colonic sensitivity
Thats around 50% more protein per day than the recommended dietary allowance (RDA) for a typical non-GLP-1-user